Sexual health, a critical component of overall well-being, is often negatively impacted following the diagnosis of haematological malignancies, yet remains an overlooked issue in patient care. A new series in The Lancet Haematology sheds light on the need for greater attention to sexual dysfunction in these patients, calling for improved management and support by healthcare providers.

The series begins with a comprehensive review that details the types of sexual health issues patients with blood cancers may face. It explores various methods for assessing sexual function and suggests practices that can improve sexual health outcomes. The lack of training and tools for care teams to address these concerns is highlighted as a major barrier to proper care.

The second paper in the series focuses specifically on sexual dysfunction following haematopoietic stem-cell transplantation, a common treatment for many blood cancers. This review delves into the physical and emotional challenges that patients experience post-transplant and emphasizes the importance of addressing these issues as part of recovery.

The third and final paper examines sexually transmitted infections (STIs) in people with haematological malignancies, an area that is often under-discussed. It stresses the need for vigilant sexual health care in this vulnerable population, given their compromised immune systems and increased susceptibility to infections.

Together, these three reviews call for a shift in how sexual health is managed for patients with haematological malignancies. They provide practical guidance to clinicians and healthcare providers, urging them to recognize and address the sexual health needs of their patients, ensuring that this vital aspect of life is not neglected during treatment.